Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses. [PDF]
Sima N +10 more
europepmc +1 more source
Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs). [PDF]
Kinarivala N, Trippier PC.
europepmc +1 more source
Case Report: A novel deep intronic <i>MFSD8</i> splice-altering variant causes CLN7 disease through pseudoexon inclusion. [PDF]
Akimova D +3 more
europepmc +1 more source
PPARα and RXRα in the regulation of neuronal ceroid lipofuscinosis genes: implications for Batten disease therapy. [PDF]
Chandra S, Pahan K.
europepmc +1 more source
A Contemporary Pathomechanistic Nosology of Inherited Lysosomal Disorders. [PDF]
McCarron EP +7 more
europepmc +1 more source
Ocular Manifestations of Neuronal Ceroid Lipofuscinoses
Neuronal ceroid lipofuscinoses (NCLs) are a group of rare neurodegenerative storage disorders associated with devastating visual prognosis, with an incidence of 1/1,000,000 in the United States and comparatively higher incidence in European countries ...
Rohan Bir Singh +2 more
exaly +2 more sources
Recent Studies of Ovine Neuronal Ceroid Lipofuscinoses From BARN, the Batten Animal Research Network
Studies on naturally occurring New Zealand and Australian ovine models of the neuronal ceroid-lipofuscinoses (Batten disease, NCLs) have greatly aided our understanding of these diseases.
Peter Houweling +2 more
exaly +3 more sources

